Background Autism spectrum disorder (ASD) is an increasingly prevalent neurodevelopmental condition with multifactorial origins, including potential prenatal environmental contributions. Maternal anemia (decreased hemoglobin [Hb] levels) has long been associated with adverse offspring neurodevelopmental outcomes. Yet, evidence regarding elevated levels of antenatal hemoglobin levels, in relation to ASD risk remains limited. This study evaluated the association between maternal Hb levels during pregnancy and the risk of ASD diagnosis in offspring. Methods This large-scale, population-based retrospective cohort study used electronic health records from births of members of Clalit Health Services (CHS), the largest health maintenance organization in Israel, between 2011 and 2021. The study included 303,234 singleton live births to Jewish mothers who had at least one measured prenatal Hb value and were CHS members. Exclusion criteria were children with known genetic disorders and births